Roche seeking earlier use for Lunsumio in FL on Phase III data
Roche is seeking a label expansion to use Lunsumio (mosunetuzumab) at an earlier stage after it showed benefit in a…
News
Everest acquires Firma’s biometrics and data services unit
China’s NMPA clears Akeso’s AK158D1 for Phase I trial in solid tumours
Altis Labs’ AI software detected treatment benefit earlier in oncology trial
Optimi Health plans Phase III trial of PTSD therapy
SpliSense begins Phase IIb SPL84 trial for cystic fibrosis
Axoltis’ Phase II ALS trial fails; company points to exploratory endpoints
Syntis Bio announces Phase I/Ib data for SYNT-101 in obesity
